FDA Commissioner and Chief Scientist Announce Decision to Withdraw Approval of Makena
http://www.fda.gov/news-events/press-announcements/fda-commissioner-and-chief-scientist-announce-decision-withdraw-approval-makena

FDA Roundup: April 4, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-april-4-2023

FDA Moves Forward with Mail-back Envelopes for Opioid Analgesics Dispensed in Outpatient Settings
http://www.fda.gov/news-events/press-announcements/fda-moves-forward-mail-back-envelopes-opioid-analgesics-dispensed-outpatient-settings

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abbott-issues-safety-notification-freestyle-librer-family-readers-us

FDA Roundup: March 31, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-march-31-2023

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/camber-pharmaceuticals-inc-issues-voluntary-nationwide-recall-atovaquone-oral-suspension-usp

http://www.fda.gov/medical-devices/medical-device-recalls/recall-datascopegetinge-certain-cardiosave-hybrid-and-rescue-intra-aortic-balloon-pumps-iabp-risk

http://www.fda.gov/medical-devices/safety-communications/evaluation-safety-concerns-certain-dental-devices-used-adults-fda-safety-communication

FDA Approves First Over-the-Counter Naloxone Nasal Spray
http://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray

FDA Roundup: March 28, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-march-28-2023